menu
    • menu

    Company profile for RVL Pharmaceuticals

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RVL Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing eyecare and medical aesthetics products. Our first FDA-approved eyecare product provides the foundation of our unwavering commitment to improve patients’ lives. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying ...
    RVL Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing eyecare and medical aesthetics products. Our first FDA-approved eyecare product provides the foundation of our unwavering commitment to improve patients’ lives. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RVL PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Crossing Blvd, Bridgewater, New Jersey 08807
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://rvlpharma.com/
    Linkedin
    Linkedin
    https://linkedin.com/company/rvl-pharmaceuticals-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RVL Pharma: Santen Gets Japan Approval For UPNEEQ Mini
    RVL Pharma: Santen Gets Japan Approval For UPNEEQ Mini

    08 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rvl-pharmaceuticals-announces-santen-obtains-manufacturing-and-marketing-approval-in-japan-for-upneeq-mini-ophthalmic-solution-0-1-302655890.html

    PR NEWSWIRE
    08 Jan 2026
    Share Share
    RVL Pharma Appoints Leaders to Accelerate Commercial Growth
    RVL Pharma Appoints Leaders to Accelerate Commercial Growth

    24 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rvl-pharmaceuticals-announces-leadership-appointments-to-accelerate-next-phase-of-growth-and-commercial-momentum-302624110.html

    PR NEWSWIRE
    24 Nov 2025
    Share Share
    Upneeq Wins 2024 Shape Skin
    Upneeq Wins 2024 Shape Skin "Best for Lift" Award

    17 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240517409527/en

    BUSINESSWIRE
    17 May 2024
    Share Share
    RVL Completes Financial Restructuring
    RVL Completes Financial Restructuring

    27 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/27/2786001/0/en/RVL-Completes-Financial-Restructuring.html

    GLOBENEWSWIRE
    27 Nov 2023
    Share Share
    RVL Pharma Announces Prepackaged Reorganization of Certain U.S. Subsidiaries
    RVL Pharma Announces Prepackaged Reorganization of Certain U.S. Subsidiaries

    12 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/12/2759072/0/en/RVL-Pharmaceuticals-plc-Announces-Prepackaged-Reorganization-of-Certain-U-S-Subsidiaries.html

    GLOBENEWSWIRE
    12 Oct 2023
    Share Share
    RVL Pharma to Present at H.C. Wainwright 25th Annual Investment Conference
    RVL Pharma to Present at H.C. Wainwright 25th Annual Investment Conference

    23 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/08/23/2730719/0/en/RVL-Pharmaceuticals-plc-to-Present-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html

    GLOBENEWSWIRE
    23 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search